Innovation for personalized theranostics
Theranostics is a very promising personalized approach to treating cancer, using diagnostic imaging to identify if target receptors are present on cancer cells, followed by precision internal radiation treatment that targets these receptors.
Making personalized theranostics a reality today
Theranostics is today mostly used in metastatic prostate cancer, liver cancer and neuroendocrine tumors.
We, at Hermes Medical solutions, believe that individualized dosimetry for each patient is essential to optimize the patient outcomes and deliver cost-effective, cutting-edge treatments.
Up until very recently, dosimetry calculations were typically achieved by a conglomeration of separate programs, pen, paper, modelling tables and more importantly a lot of willingness, dedication, and time from an expert user. Planar-based models and phantom dosimetry estimations can cause up to 30% inaccuracy. Using our latest voxel-based Monte-Carlo algorithm reduces this 2 to 3 fold.
“With the theranostics approach in cancer, one can more judiciously choose not only for a very specific patient the most suitable treatment, both at the level of molecules and doses, but also apply innovative treatments.”
- Dr. François Lamoureux, Associate Professor of Clinical Medicine in Nuclear Medicine at the Faculty of Medicine - University of Montreal, President of CANM
Personalized Dosimetry is Essential for NETs
Peptide receptor radionuclide therapy (PRRT) is a powerful tool in the fight against neuro-endocrine tumors (NETs). But the complexities of tailoring the treatment to each individual patient present a challenge to both clinical departments and software companies. In this article we describe a multi-disciplinary effort to overcome the challenges and deliver the optimal treatment for patients.
Innovations for personalized, fast and accurate dosimetry
To support all your clinical workflows
Browse to read more about all the many possibilities offered by Hermia– our ALL-IN-ONE state-of-the-art software suite. You can pick and choose the specialities and tools adapted to your current clinical needs and scale up whenever new possibilities arise.
Voxel Dosimetry™ is CE marked and has 510(k) clearance for a wide range of therapy and imaging isotopes - making it the only complete voxel dosimetry software on the market suitable for personalized dosimetry.
Organ Dosimetry™ provides a seamless workflow, enabling the user to perform all steps using only one interface.
Hermia's SPECT reconstruction is optimized for speed and a wide range of procedures, radio-pharmaceuticals and collimators, making it possible to improve image quality while reducing dose and acquisition time from all your SPECT/CT cameras.
Handle all your oncology work from diagnostic imaging, reporting to therapy for all modalities and scanners.